NCT04978077

Brief Summary

Probands with an Ileo- or Colostomy are assigned to consume a test meal which is either high in fat or high in carbohydrates. After the test meal samples from the stoma, urine, blood and skin are retrieved. These will be subjected to large scale analyses of microbiota and metabolite content. To get a better comparability test subjects will consume a standardized liquid diet three days before the study day.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

December 16, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

3 years

First QC Date

July 12, 2021

Last Update Submit

December 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Identification of stimulating and inhibiting metabolite and bacteria interactions

    Correlation of results of secondary outcome measures to find interactions

    8 hours

  • Reproduction of metabolite-bacteria interactions in vitro culture

    By culturing of bacteria with possible interactions together in vitro

    2 weeks

Secondary Outcomes (10)

  • Analysis of bacteria species composition

    8 hours

  • Cultivation of bacterial strains in various conditions including ileal fluids

    2 weeks

  • Metabolite composition in intestinal fluids

    8 hours

  • Metabolite composition in blood

    8 hours

  • Metabolite composition in urine

    8 hours

  • +5 more secondary outcomes

Study Arms (2)

High fat test meal first, high carbohydrate test meal second

EXPERIMENTAL

Consumption of a high fat challenge first, consumption of a high carbohydrate challenge after two weeks wash out

Other: Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)

High carbohydrate test meal first, high fat test meal second

EXPERIMENTAL

Consumption of a high carbohydrate challenge first, consumption of a high fit challenge after two weeks wash out

Other: Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)

Interventions

After a night fast participants will drink the test meal

High carbohydrate test meal first, high fat test meal secondHigh fat test meal first, high carbohydrate test meal second

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • General good health
  • Ileostomy or colostomy

You may not qualify if:

  • Hematologic disorders with contraindication of blood draw
  • Participation in other clinical trial interfering with study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inselspital

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Communicable Diseases

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Benjamin Misselwitz, Prof. Dr. med.

    University Clinic for Visceral Surgery and Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2021

First Posted

July 27, 2021

Study Start

December 16, 2021

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Sequencing data will be shared in a public repository

Time Frame
upon publication of study results open ended
Access Criteria
public access

Locations